CENTONZE, MATTEO
CENTONZE, MATTEO
Co-expression of CD133+/CD44+ in human colon cancer and liver metastasis
2013-01-01 Bellizzi, A.; Sebastian, S.; Ceglia, P.; Centonze, M.; Divella, R.; Manzillo, E. F.; Azzariti, A.; Silvestris, N.; Montemurro, S.; Caliandro, C.; De Luca, R.; Cicero, G.; Rizzo, S.; Russo, A.; Quaranta, M.; Simone, G.; Paradiso, A.
Hierarchical clustering analysis identifies metastatic colorectal cancers patients with more aggressive phenotype
2017-01-01 Opinto, G.; Silvestris, N.; Centonze, M.; Graziano, G.; Pinto, R.; Fucci, L.; Simone, G.; Mangia, A.
NHERF1 and tumor microenvironment: A new scene in invasive breast carcinoma
2018-01-01 Saponaro, C.; Vagheggini, A.; Scarpi, E.; Centonze, M.; Catacchio, I.; Popescu, O.; Pastena, M. I.; Giotta, F.; Silvestris, N.; Mangia, A.
NURR1 downregulation favors osteoblastic differentiation of MSCs
2017-01-01 DI BENEDETTO, Adriana; Posa, Francesca; Carbone, Claudia; Cantore, Stefania; Brunetti, Giacomina; Centonze, Matteo; Grano, Maria; LO MUZIO, Lorenzo; Cavalcanti Adam, Elisabetta A.; Mori, Giorgio
Should tumor infiltrating lymphocytes, androgen receptor, and FOXA1 expression predict the clinical outcome in triple negative breast cancer patients?
2019-01-01 Mangia, A.; Saponaro, Concetta; Vagheggini, A.; Opinto, G.; Centonze, M.; Vicenti, C.; Popescu, O.; Pastena, M.; Giotta, F.; Silvestris, N.
Soluble Decoy Receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients
2009-01-01 Colucci, S; Brunetti, G; Mori, G; Oranger, A; Centonze, M; Mori, C; Cantatore, Fp; Tamma, R; Rizzi, R; Liso, V; Zallone, A; Grano, M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Co-expression of CD133+/CD44+ in human colon cancer and liver metastasis | 1-gen-2013 | Bellizzi, A.; Sebastian, S.; Ceglia, P.; Centonze, M.; Divella, R.; Manzillo, E. F.; Azzariti, A.; Silvestris, N.; Montemurro, S.; Caliandro, C.; De Luca, R.; Cicero, G.; Rizzo, S.; Russo, A.; Quaranta, M.; Simone, G.; Paradiso, A. | |
Hierarchical clustering analysis identifies metastatic colorectal cancers patients with more aggressive phenotype | 1-gen-2017 | Opinto, G.; Silvestris, N.; Centonze, M.; Graziano, G.; Pinto, R.; Fucci, L.; Simone, G.; Mangia, A. | |
NHERF1 and tumor microenvironment: A new scene in invasive breast carcinoma | 1-gen-2018 | Saponaro, C.; Vagheggini, A.; Scarpi, E.; Centonze, M.; Catacchio, I.; Popescu, O.; Pastena, M. I.; Giotta, F.; Silvestris, N.; Mangia, A. | |
NURR1 downregulation favors osteoblastic differentiation of MSCs | 1-gen-2017 | DI BENEDETTO, Adriana; Posa, Francesca; Carbone, Claudia; Cantore, Stefania; Brunetti, Giacomina; Centonze, Matteo; Grano, Maria; LO MUZIO, Lorenzo; Cavalcanti Adam, Elisabetta A.; Mori, Giorgio | |
Should tumor infiltrating lymphocytes, androgen receptor, and FOXA1 expression predict the clinical outcome in triple negative breast cancer patients? | 1-gen-2019 | Mangia, A.; Saponaro, Concetta; Vagheggini, A.; Opinto, G.; Centonze, M.; Vicenti, C.; Popescu, O.; Pastena, M.; Giotta, F.; Silvestris, N. | |
Soluble Decoy Receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients | 1-gen-2009 | Colucci, S; Brunetti, G; Mori, G; Oranger, A; Centonze, M; Mori, C; Cantatore, Fp; Tamma, R; Rizzi, R; Liso, V; Zallone, A; Grano, M |